VEXAS syndrome

PC Grayson, BA Patel, NS Young - Blood, The Journal of the …, 2021 - ashpublications.org
VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) is a
monogenic disease of adulthood caused by somatic mutations in UBA1 in hematopoietic …

An update on VEXAS syndrome

A Al-Hakim, S Savic - Expert Review of Clinical Immunology, 2023 - Taylor & Francis
Introduction VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome
is a recently described, late-onset, acquired autoinflammatory disorder caused by mutations …

Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients

S Georgin‐Lavialle, B Terrier… - British Journal of …, 2022 - academic.oup.com
Background A new autoinflammatory syndrome related to somatic mutations of UBA1 was
recently described and called VEXAS syndrome ('Vacuoles, E1 Enzyme, X‐linked …

Clinical heterogeneity of the VEXAS syndrome: a case series

MJ Koster, T Kourelis, KK Reichard, TA Kermani… - Mayo Clinic …, 2021 - Elsevier
The objective of this study is to describe the clinical features and outcomes of patients with
the newly defined vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) …

VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation

O Kosmider, C Possémé, M Templé, A Corneau… - Nature …, 2024 - nature.com
Acquired mutations in the UBA1 gene were recently identified in patients with severe adult-
onset auto-inflammatory syndrome called VEXAS (vacuoles, E1 enzyme, X-linked …

VEXAS syndrome: a case series from a single‐center cohort of Italian patients with vasculitis

F Muratore, C Marvisi, P Castrignanò… - Arthritis & …, 2022 - Wiley Online Library
Objective To identify patients with VEXAS syndrome (vacuoles, E1 enzyme, X‐linked,
autoinflammatory, somatic syndrome) from a single‐center cohort of Italian patients with …

Toward a pathophysiology inspired treatment of VEXAS syndrome

M Heiblig, BA Patel, EM Groarke, E Bourbon… - Seminars in …, 2021 - Elsevier
VEXAS syndrome has an unmet need for therapeutic interventions. Even if few data exist
regarding the treatment of this newly described syndrome, different options can be proposed …

Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan

Y Kirino, K Takase-Minegishi, N Tsuchida… - Annals of the …, 2021 - ard.bmj.com
Recently, a rare severe autoinflammatory disease vacuoles, E1 enzyme, X-linked,
autoinflammatory, somatic (VEXAS) syndrome caused by somatic variants in the UBA1 gene …

Early activation of inflammatory pathways in UBA1-mutated hematopoietic stem and progenitor cells in VEXAS

Z Wu, S Gao, Q Gao, BA Patel, EM Groarke, X Feng… - Cell Reports …, 2023 - cell.com
Summary VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a
pleiotropic, severe autoinflammatory disease caused by somatic mutations in the ubiquitin …

Clonal hematopoiesis, inflammation, and hematologic malignancy

R Kanagal-Shamanna, DB Beck… - Annual Review of …, 2024 - annualreviews.org
Somatic or acquired mutations are postzygotic genetic variations that can occur within any
tissue. These mutations accumulate during aging and have classically been linked to …